Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Sage Therapeutic Com (SAGE)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Latest Headlines for [[ item.sessionDateDisplayLong ]]
Sage Therapeutics to Participate in Leerink Investor Conference

Sage Therapeutics (NASDAQ: SAGE), a clinical-stage biopharmaceutical company developing novel medicines to treat life-altering central nervous system (CNS) disorders, today announced that...

SAGE : 63.32 (+3.08%)
Implied Volatility Surging for Sage Therapeutics, Inc. (SAGE) Stock Options

Surging implied volatility makes Sage Therapeutics, Inc. (SAGE) stock lucrative to the option traders.

SAGE : 63.32 (+3.08%)
Corporate News Blog - Sage Therapeutics Announces Top-Line Results from Phase-3 STATUS Trial of Brexanolone

Research Desk Line-up: Cellect Biotech Post Earnings Coverage

SAGE : 63.32 (+3.08%)
APOP : 7.98 (+1.92%)
Biotech Stock Roundup: Alexion to Cut Jobs, Streamline Operations, Kura Up on Cancer Data

Key highlights include Alexion's (ALXN) restructuring plans and promising data from Kura Oncology on its lead pipeline candidate.

VRTX : 155.05 (+0.23%)
KURA : 14.10 (unch)
SAGE : 63.32 (+3.08%)
ABBV : 92.17 (+1.24%)
REGN : 442.56 (-0.70%)
ICPT : 67.06 (-0.46%)
ALXN : 143.16 (+1.65%)
DowDuPont and US Bancorp climb while Cooper Cos. slides

NEW YORK (AP) — Stocks that moved substantially or traded heavily Tuesday:

SAGE : 63.32 (+3.08%)
ALXN : 143.16 (+1.65%)
Sage Therapeutics Reports Top-Line Results from Phase 3 STATUS Trial of Brexanolone in Super-Refractory Status Epilepticus

Sage Therapeutics (NASDAQ: SAGE), a clinical-stage biopharmaceutical company developing novel medicines to treat life-altering central nervous system (CNS) disorders, today reported top-line...

SAGE : 63.32 (+3.08%)
Sage Therapeutics to Present at Morgan Stanley Healthcare Conference

Sage Therapeutics (NASDAQ: SAGE), a clinical-stage biopharmaceutical company developing novel medicines to treat life-altering central nervous system (CNS) disorders, today announced that...

MS : 49.12 (+0.37%)
SAGE : 63.32 (+3.08%)
Sage Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Sage Therapeutics (NASDAQ: SAGE), a clinical-stage biopharmaceutical company developing novel medicines to treat life-altering central nervous system (CNS) disorders, announced that, on September...

SAGE : 63.32 (+3.08%)
Options Traders Expect Huge Moves in Sage Therapeutics (SAGE) Stock

Options Traders Expect Huge Moves in Sage Therapeutics (SAGE) Stock on the back of its high level of implied volatility.

SAGE : 63.32 (+3.08%)
Sage Therapeutic Has Returned 23.1% Since SmarTrend Recommendation (SAGE)

SmarTrend identified an Uptrend for Sage Therapeutic (NASDAQ:SAGE) on June 7th, 2017 at $71.91. In approximately 2 months, Sage Therapeutic has returned 23.08% as of today's recent price of $88.51.

SAGE : 63.32 (+3.08%)
Today's Research Reports on Stocks to Watch: Neurocrine Biosciences and Sage Therapeutics

NEW YORK, NY / ACCESSWIRE / August 7, 2017 / Despite a wider net loss in the second quarter than compared to a year ago, shares of Neurocrine still closed up nearly 10% on Friday after reporting impressive...

NBIX : 60.87 (-0.44%)
SAGE : 63.32 (+3.08%)
Sage Therapeutic Rises 12.39% on Heavy Volume: Watch For Potential Pullback

Sage Therapeutic (NASDAQ:SAGE) traded in a range yesterday that spanned from a low of $78.61 to a high of $88.26. Yesterday, the shares gained 12.4%, which took the trading range above the 3-day high...

SAGE : 63.32 (+3.08%)
Sage Therapeutics Announces Second Quarter 2017 Financial Results and Provides Pipeline Update

--Positive scientific advice from European Medicines Agency on development of brexanolone in PPD provides regulatory path in EU

SAGE : 63.32 (+3.08%)
Investor Network: SAGE Therapeutics, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / August 3, 2017 / SAGE Therapeutics, Inc. (NASDAQ: SAGE) will be discussing their earnings results in their Q2 Earnings Call to be held on Thursday, August 3, 2017 at 4:30 PM...

SAGE : 63.32 (+3.08%)
Investor Network: SAGE Therapeutics, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / August 3, 2017 / SAGE Therapeutics, Inc. (NASDAQ: SAGE) will be discussing their earnings results in their Q2 Earnings Call to be held on Thursday, August 3, 2017 at 4:30 PM...

SAGE : 63.32 (+3.08%)
Interesting SAGE Put And Call Options For February 2018

Investors in Sage Therapeutics Inc saw new options become available this week, for the February 2018 expiration. One of the key data points that goes into the price an option buyer is willing to pay,...

SAGE : 63.32 (+3.08%)
5 Top Stocks to Own

Today I sorted Barchart's Top Stocks to Own list first by the highest Weighted Alpha, then by technical buy signals of 80% or more and lastly used the FlipChart feature to review the charts...

ENZ : 10.00 (-3.29%)
TDOC : 34.00 (+3.98%)
NVTR : 13.91 (-0.36%)
SAGE : 63.32 (+3.08%)
PI : 35.96 (+2.80%)
Noteworthy Friday Option Activity: SAGE, BV, ALGN

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Sage Therapeutics Inc , where a total of 1,576 contracts have traded so far, representing approximately...

SAGE : 63.32 (+3.08%)
Sage Therapeutics to Present at Goldman Sachs Healthcare Conference

Sage Therapeutics (NASDAQ: SAGE), a clinical-stage biopharmaceutical company developing novel medicines to treat life-altering central nervous system (CNS) disorders, today announced that...

SAGE : 63.32 (+3.08%)
Sage Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Sage Therapeutics (NASDAQ:SAGE), a clinical-stage biopharmaceutical company developing novel medicines to treat life-altering central nervous system (CNS) disorders, announced that, on June...

SAGE : 63.32 (+3.08%)

Van Meerten Stock Picks

5 Great Small Caps
Today I wanted to find 5 Small Cap stocks that had great returns but still had some momentum left.
KEM +0.41 , SPPI +0.52 , ITGR -0.40 , ESIO +0.13 , ASIX -0.38
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

Barchart Morning Call

OVERNIGHT MARKETS AND NEWS Dec E-mini S&Ps ( ESZ17 -0.02% ) this morning are little changed, down -0.03% , and European stocks are up +0.08%. U.S. stock indexes were consolidating their gains from Monday's rally to new all-time highs. The... Read More

Chart of the Day

Chart of the Day

Ichor (ICHR) is the Barchart Chart of the Day.  The Semiconductor company has a Trend Spotter buy signal. a Weighted Alpha of 226.41+ and gained 239.41% in the last year.
Read More

Brugler Ag Report

Today's Commentary

Corn futures settled Tuesday with most contracts fractionally to 1 1/2 cents lower.  The USDA announced separate private export sales of 146,000 MT to unknown destinations and 115,000 MT to Mexico for 17/18 delivery through their daily reporting...
Read More

Alan Brugler writes this daily agricultural markets overview with opening, midday and closing comments directed at the gain and meat Ag markets.

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart